BCYC — BICYCLE THERAPEUTICS PLC

Ownership history in Birchview Capital, LP  ·  2 quarters on record

This page tracks every 13F SEC filing in which Birchview Capital, LP reported a position in BICYCLE THERAPEUTICS PLC (BCYC). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
1.92% (2025 Q4)
Avg. % of fund
1.41%
First filed
2025 Q3
Last filed
2025 Q4
Quarters held
2
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 ADDED 462,700 +308,700 +200.5% 1.92% $3.3M $7.08
2025 Q3 INITIATED 154,000 — — 0.90% $1.2M $7.74
% of Fund (quarterly)    BCYC price (monthly, adj. close)

Other funds also holding BCYC

As of 2025 Q4 — sorted by position size

FCPM III SERVICES B.V. 3.22% GSK plc 1.36% FLAX POND CAPITAL, LLC 0.91% Rangeley Capital, LLC 0.78% BAKER BROS. ADVISORS LP 3Y 7Y 0.45% MONIMUS CAPITAL MANAGEMENT, LP 0.44% Nan Fung Group Holdings Ltd 3Y 0.44% Siren, L.L.C. 0.43% Long Focus Capital Management, LLC 3Y 0.3% PLATINUM INVESTMENT MANAGEMENT LTD 3Y 7Y 0.3%
← Back to Birchview Capital, LP Holdings